Press-release for stocks

Prices are updated after-hours

crawled time : 07:00 source : Www.biospace.com

save search

Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - April 11, 2024
Published: 2024-04-11 (Crawled : 07:00) - biospace.com/
MIRM | News | $23.83 1.1% 1.09% 340K

Health Technology

| -6.99% | O: -0.35% H: 1.98% C: 1.25%
nasdaq pharmaceuticals grants

United States Food & Drug Administration Notifies Mesoblast that Available Clinical Data from Phase 3 Trial Appear Sufficient to Support BLA Submission for Remestemcel-L in Children with Steroid-Refractory Acute Graft Versus Host Disease
Published: 2024-03-26 (Crawled : 07:00) - biospace.com/
MESO | $5.19 1.57% 1.54% 230K

Health Technology

| 136.82% | O: 23.18% H: 0.0% C: 0.0%
drug disease children food trial submission

ObsEva Announces Update on Board of Directors - March 19, 2024
Published: 2024-03-19 (Crawled : 07:00) - biospace.com/
OBSV | $0.1018 -15.52% -18.95% 8.2M

Health Technology

| Email alert Add to watchlist
update

Innate Pharma Announces Its Participation to Upcoming March 2024 Investor Conference
Published: 2024-02-21 (Crawled : 07:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K

Health Technology

| -1.49% | O: 1.7% H: 0.0% C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M

Health Technology

| -2.32% | O: -0.57% H: 0.0% C: 0.0%
IPHA | $2.48 5.53% 5.24% 9.4K

Health Technology

| -5.79% | O: -2.32% H: 0.0% C: 0.0%
pharma conference

NanoString Takes Steps to Restructure Its Business and Protect Its Mission to Map the Universe of Biology
Published: 2024-02-05 (Crawled : 07:00) - biospace.com/
NSTG M | $0.1053 -37.43% -0.19% 0

Health Technology

| -78.94% | O: -63.18% H: 0.0% C: 0.0%
TXG | $27.92 -3.56% -3.69% 2M

Health Technology

| -35.92% | O: -1.72% H: 2.15% C: 0.42%
business

Experts Take a ‘Wait and See’ Approach as BTK Inhibitors Stumble in MS
Published: 2024-01-29 (Crawled : 07:00) - biospace.com/
SNY | News | $46.32 2.05% 2.01% 3.3M

Health Technology

| -7.68% | O: 0.12% H: 0.0% C: 0.0%

Sagimet Biosciences Announces Pricing of Public Offering of Series A Common Stock - Jan 26, 2024
Published: 2024-01-26 (Crawled : 07:00) - biospace.com/
SGMT | $4.0 0.76% 0.75% 430K

Health Technology

| -71.4% | O: -8.2% H: 2.87% C: -17.09%
series offering

Top 5 Biopharma Companies Hiring Engineers
Published: 2024-01-25 (Crawled : 07:00) - biospace.com/
LLY | News | $726.31 -2.63% -0.04% 3.5M

Health Technology

| 14.61% | O: -1.0% H: 0.84% C: 0.04%
companies biopharma

PhRMA, BIO Push Back Against Rare String of Setbacks
Published: 2024-01-24 (Crawled : 07:00) - biospace.com/
JNJ | News | $147.91 1.49% -0.03% 9.6M

Health Technology

| -7.65% | O: -0.32% H: 0.0% C: 0.0%
rare back

InnoCare Announces First Prescription of Tafasitamab in Combination with Lenalidomide for Relapsed or Refractory Diffuse Large B-Cell Lymphoma Under Greater Bay Area’s Early Access Program
Published: 2024-01-22 (Crawled : 07:00) - biospace.com/
XNCR | $18.385 -2.98% -3.07% 830K

Health Technology

| -6.42% | O: 0.56% H: 1.97% C: 1.37%
MOR | News | $17.96 -0.5% -0.5% 180K

Health Technology

| 96.07% | O: 0.11% H: 1.96% C: -0.27%
first bay program

6 Neuro Data Readouts to Watch in the First Half of 2024
Published: 2024-01-22 (Crawled : 07:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K

Health Technology

| -8.68% | O: 1.71% H: 0.0% C: -0.15%
SNY | News | $46.32 2.05% 2.01% 3.3M

Health Technology

| -9.64% | O: -0.21% H: 0.0% C: 0.0%
first

Thermo Fisher Scientific Receives GMP approval from the Italian Medicines Agency (AIFA) for its Manufacturing facility of RNA-Based Products in Monza, Italy
Published: 2024-01-19 (Crawled : 07:00) - biospace.com/
TMO | News | $544.78 0.6% 0.0% 1.7M

Health Technology

| 1.43% | O: 1.46% H: 0.0% C: 0.0%
approval

Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Jan 11, 2024
Published: 2024-01-11 (Crawled : 07:00) - biospace.com/
MIRM | News | $23.83 1.1% 1.09% 340K

Health Technology

| -9.33% | O: 0.04% H: 3.88% C: 2.32%
nasdaq pharmaceuticals grants

Companies Bend Patent System to Head Off Competition Long-Term: Analysis
Published: 2024-01-10 (Crawled : 07:00) - biospace.com/
JNJ | News | $147.91 1.49% -0.03% 9.6M

Health Technology

| -8.47% | O: 0.06% H: 0.0% C: 0.0%
patent companies system

Opinion: Brain Health Matters; We Must Not Lose Momentum
Published: 2024-01-08 (Crawled : 07:00) - biospace.com/
ALNY | $144.315 -0.58% -0.59% 700K

Health Technology

| -23.75% | O: -0.05% H: 4.12% C: 3.98%
health momentum

Market for CAR-Ts Still Bright Despite FDA Cancer Safety Review
Published: 2023-12-20 (Crawled : 07:00) - biospace.com/
JNJ | News | $147.91 1.49% -0.03% 9.6M

Health Technology